Educational protocol hub
LL-37: protocol variants and reconstitution resources
Educational hub for LL-37, grouping 1 available protocol variant with links to the exact dosage and reconstitution pages.
What this hub covers
This page groups the available LL-37 protocol variants so readers can choose the exact vial-size guide without mixing formats.
Reconstitution workflow
Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.
Research-only context
All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.
Available protocol variants
Choose the exact guide you want to view.
LL-37
LL-37 (also known as CAP-18) is a 37-amino acid cationic antimicrobial peptide derived from the C-terminus of human cathelicidin (hCAP18). It is the only known human cathelicidin, exhibiting broad-spectrum antimicrobial activity and immunomodulatory properties. This protocol outlines a once-daily subcutaneous approach.
View protocolRelated research resources
Internal links that help readers and search engines understand this peptide topic cluster.
References
- Wound Repair Regen (PMC, 2022) — LL-37 in healing hard-to-heal venous leg ulcers: a multicenter RCT
View Source - J Immunol (PMC, 2013) — Small peptide, big effects: the role of LL-37 in inflammation
View Source - Innate Immun (PMC, 2020) — LL-37 ameliorates sepsis via neutrophil-derived microvesicles
View Source - Arch Dermatol Res (PMC, 2023) — LL-37 cream in diabetic foot ulcers: RCT
View Source - White JH J Steroid Biochem Mol Biol 2010 — Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future.
View Source
Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.